Validated Transdermal GFR Measurement in Kidney Disease Models

Validated Transdermal GFR Measurement in Kidney Disease Models

At InnoSer, we offer several readouts to assess the disease progression and the efficacy of novel targeted polycystic kidney disease (PKD) compounds. However, we understand that it remains a significant challenge to access crucial readouts that are recognized by...
Immunophenotyping to Evaluate Efficacy of Novel Immunotherapies

Immunophenotyping to Evaluate Efficacy of Novel Immunotherapies

It is well-established that syngeneic tumour models represent a powerful tool to evaluate therapies that target the immune system. The key to understanding your immuno-modulatory compound’s efficacy is to work with well-characterised models, with known growth...
Auditory Event-Related Potentials EEG-Recording in Fmr1 KO mice

Auditory Event-Related Potentials EEG-Recording in Fmr1 KO mice

July is Fragile X Syndrome (FXS) Awareness month, a time dedicated to raising awareness about this rare genetic disorder, affecting thousands of individuals worldwide. We are deeply committed to accelerating the availability of targeted therapies to improve the lives...
Auditory Event-Related Potentials EEG-Recording in Fmr1 KO mice

EEG Recording in the Epileptic Encephalopathy Model

September is STXBP1 disorders awareness month, an initiative aimed at raising awareness of STXBP1-related rare genetic disorders, such as epileptic encephalopathy. Although STXBP1-related disorders are rare; STXBP1 is the 5th most common cause of genetic forms of...